To include your compound in the COVID-19 Resource Center, submit it here.
In its safety review of fatty acid amide hydrolase ( FAAH) inhibitors, FDA concluded that BIA 10-2474 from Bial-Portela & Ca. S.A.
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury